Interleukin 6: A biomarker for COVID-19 progression
Research article
[키워드] “cytokine storm”
Biomarker
caused
China
clinical trial
Concentration
COVID
COVID-19
COVID-19 progression
CRS
cytokine
Cytokine release syndrome
Cytokine storm
Diagnosis
disease
Health
highlight
IL-6
IL-6 level
immune system
immunoregulation
Infection
Inflammation
inhibited
interleukin
interleukin-6
massive inflammatory
monoclonal antibodies
monoclonal antibody
morbidity and mortality
multi-organ dysfunction
pandemic
Patient
pleiotropic
pro-inflammatory cytokines
progression
receptor
reduce
reducing
Respiratory failure
resulting
SARS-CoV-2
serum
severe complications
severity of COVID-19
significantly
therapeutic target
through contact
transmitted
Treatment
World Health Organization
zoonotic
[DOI] 10.1016/j.matpr.2022.07.387 [Article Type] Research article
[DOI] 10.1016/j.matpr.2022.07.387 [Article Type] Research article